Literature DB >> 7235680

Synergy of penicillin and decreasing concentration of aminoglycosides against enterococci from patients with infective endocarditis.

J Y Matsumoto, W R Wilson, A J Wright, J E Geraci, J A Washington.   

Abstract

To determine whether low concentrations of aminoglycosides in combination with penicillin could effectively kill enterococci in vitro, we tested penicillin (20 micrograms/ml) in combination with decreasing concentrations of either streptomycin (20, 10, 5, and 1 micrograms/ml) or gentamicin (5, 3, 1, and 0.5 micrograms/ml) against 13 strains of streptomycin-susceptible and 7 strains of streptomycin-resistant enterococci isolated from patients with infective endocarditis. At 24 h, penicillin plus each increment in streptomycin concentration resulted in a statistically significant increase in killing of streptomycin-susceptible enterococci, compared with the next lower streptomycin concentration (P less than 0.01). At 24 h, against streptomycin-susceptible and streptomycin-resistant enterococci, there were no statistically significant differences in killing between combinations containing 5 micrograms of gentamicin per ml and those containing 3 micrograms/ml. Against streptomycin-susceptible enterococci, there were statistically significant differences in killing between combinations containing 3 micrograms of gentamicin per ml and those containing 1 micrograms/ml. Against streptomycin-resistant enterococci, statistically significant differences in killing were detected with combinations containing 5 micrograms of gentamicin per ml and those containing 1 microgram/ml.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7235680      PMCID: PMC352994          DOI: 10.1128/AAC.18.6.944

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  5 in total

1.  Enterococcal endocarditis. An analysis of 38 patients observed at the New York Hospital-Cornell Medical Center.

Authors:  G L Mandell; D Kaye; M E Levison; E W Hook
Journal:  Arch Intern Med       Date:  1970-02

2.  Synergy of penicillin and gentamicin against Enterococci.

Authors:  R C Moellering; C Wennersten; A N Weinberg
Journal:  J Infect Dis       Date:  1971-12       Impact factor: 5.226

3.  Penicillin combined with gentamicin or streptomycin: synergism against enterococci.

Authors:  C Watanakunakorn
Journal:  J Infect Dis       Date:  1971-12       Impact factor: 5.226

4.  Studies on antibiotic synergism against enterococci. I. Bacteriologic studies.

Authors:  R C Moellering; C Wennersten; A N Weinberg
Journal:  J Lab Clin Med       Date:  1971-05

5.  Antibiotic synergism of enterococci. Relation to inhibitory concentrations.

Authors:  H D Standiford; J B De Maine; W M Kirby
Journal:  Arch Intern Med       Date:  1970-08
  5 in total
  13 in total

Review 1.  In vivo antibiotic synergism: contribution of animal models.

Authors:  B Fantin; C Carbon
Journal:  Antimicrob Agents Chemother       Date:  1992-05       Impact factor: 5.191

Review 2.  Screening and treatment of infections caused by resistant enterococci.

Authors:  D J Herman; D N Gerding
Journal:  Antimicrob Agents Chemother       Date:  1991-02       Impact factor: 5.191

Review 3.  The life and times of the Enterococcus.

Authors:  B E Murray
Journal:  Clin Microbiol Rev       Date:  1990-01       Impact factor: 26.132

4.  Influence of gentamicin dose size on the efficacies of combinations of gentamicin and penicillin in experimental streptomycin-resistant enterococcal endocarditis.

Authors:  A J Wright; W R Wilson; J Y Matsumoto; J A Washington; J E Geraci
Journal:  Antimicrob Agents Chemother       Date:  1982-12       Impact factor: 5.191

5.  Pharmacokinetic modeling of gentamicin in treatment of infective endocarditis: Model development and validation of existing models.

Authors:  Anna Gomes; Lars van der Wijk; Johannes H Proost; Bhanu Sinha; Daan J Touw
Journal:  PLoS One       Date:  2017-05-05       Impact factor: 3.240

6.  In vitro response to bactericidal activity of cell wall-active antibiotics does not support the general opinion that enterococci are naturally tolerant to these antibiotics.

Authors:  R Fontana; A Grossato; M Ligozzi; E A Tonin
Journal:  Antimicrob Agents Chemother       Date:  1990-08       Impact factor: 5.191

7.  Vancomycin and gentamicin pharmacokinetic alterations in an adolescent amputee.

Authors:  Kristen R Nichols; Kari M Edison; Michelle D Rosenbaum; Chad A Knoderer
Journal:  J Pediatr Pharmacol Ther       Date:  2013-01

8.  Antibiotic prophylaxis against streptomycin-resistant and -susceptible Streptococcus faecalis endocarditis in rabbits.

Authors:  P A Guze; G M Kalmanson; L R Freedman; K Ishida; L B Guze
Journal:  Antimicrob Agents Chemother       Date:  1983-10       Impact factor: 5.191

9.  Antibiotic-induced lysis of enterococci.

Authors:  G A Storch; D J Krogstad
Journal:  J Clin Invest       Date:  1981-09       Impact factor: 14.808

10.  Treatment of streptomycin-susceptible enterococcal experimental endocarditis with combinations of penicillin and low- or high-dose streptomycin.

Authors:  N K Henry; W R Wilson; J E Geraci
Journal:  Antimicrob Agents Chemother       Date:  1986-11       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.